Medice Arzneimittel Pütter GmbH & Co KG
11
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
18.2%
2 terminated/withdrawn out of 11 trials
81.8%
-4.8% vs industry average
45%
5 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment reporting
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
A Study to See if a Combination of Vitamins That is Injected Into a Muscle is as Good and Safe as a Vitamin That is Taken by Mouth
Role: lead
The Effect of Sodium Bicarbonate (Nephrotrans®) on Calcification Propensity of Serum in Kidney Transplant Recipients
Role: collaborator
Efficacy and Safety of Alflorex Bei Reizdarm in Patients With Irritable Bowel Syndrome
Role: lead
Attentin® in Children and Adolescents With ADHD - A Non-interventional Study
Role: lead
Efficacy and Tolerability of a Phytotherapy Combination (Aqualibra) in Patients With Uncomplicated Cystitis
Role: lead
Safety and Efficacy of a Sore Throat Lozenge DORITHRICIN in Patients With Acute Pharyngitis
Role: lead
Integrated Diagnosis and Treatment of Adults With Attention-deficit/Hyperactivity Disorder
Role: lead
Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
Role: lead
Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA
Role: lead
Methylphenidate Treatment of Cancer-Related Fatigue
Role: lead
Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD
Role: lead
All 11 trials loaded